News About: Goverment
Dissented revised bill of pharmaceutical affairs law to reject its pass.
In the parliamentary audit from Nov. 6 to 7, the Health and Welfare Committee of the National Assembly sharply criticized the government's immatured medical reform programs and strongly urged to extract a people's con...
Bio-equivalent test required for special dosage formed drugs.
Mr. Yang Kyu-whan, the head administrator of the KFDA reported in the Parliamentary Inspection of Government administration that cardiac, anti-cancer and anti-convulsant drugs, a relatively narrow range of its safety,...
Substitutive dispensing issue closely to accord in tripartite meeting.
From Oct. 31 the tripartite meeting behan to discuss current medical reform issues only to identify their different opinions at the lst meeting, and then established a working-level subcommittee in the 2nd meeting to ...
Business collusion between medical institutes and pharmacies to prohibit.
Mr. Lee Kyung-ho, the chief officer of the Planning and Administration, MOHW said on Oct. 31 that the government and the pharmacy association agreed to set up an earlier soft landing of the government's medical refor...
KPMA imperatively to request insurance standard price compliance to wholesalers.
The KPMA expressed a deep regret to the FTC and asked for improvement of the provision against the recent FTC's warning measures, claiming that the industry's policy over the insurance drug standard prices is one of c...
Tripartite meeting of government, medical and pharmacy groups to debate on hot issues.
The tripartite meeting among the government, the medical and the pharmacy organizations began to talk from Oct. 31 to discuss many hot issues including the substitutive dispensing problems, drug reclassification and s...
Drug prescription by generic or brand name on hot issue.
The 2nd tripartite meeting on Nov. 2 opened but soon suspended only after identifying bipolar positions between the medical and the pharmacy communities. The 3rd meeting was soon resumed at 8 p.m.
Following the tri...
FTC ordered KPMA and 39 drug companies to correct unfair trade practices.
After the insurance drug pricing policy was changed and adopted to the Actual Purchasing Price Reimbursement system along with implementation of the government's medical and pharmacy role separation program, most of l...
KPA raised 27 proposals in talks with government.
The KPA has prepared 27 different subjects to propose in the forthcoming talks with the government, including removal of prior physician's agreement obligation for substitutive dispensing at pharmacies and dispensing ...
Cisapride preparations stopped market supply from Oct. 25.
The KFDA stopped market supplying of Cisapride preparations, a gastrointestinal drug, from Oct. 25, and Janssen Korea, the supplier of Cisapride, and other 10 companies expressed to accept the measure.
The KFDA ins...
